Healthcare
Scottish Venture Fund joins £9.6m round for TPP
The Scottish Venture Fund has joined a ТЃ9.6m funding round for drug development company, TPP Global Development.
Berchmann Capital leads €1.2m round for Genolab
Berchmann Capital has led a €1.2m series-A round for medical diagnostics company Genolab.
Procuritas acquires Oral Care
Procuritas has acquired Swedish mobile dentistry company, Oral Care.
LBO France to sell Medi-Partenaires
LBO France is planning to sell its stake in French clinic operator Medi-Partenaires, according to media reports.
PINOVA Capital takes a participation in Hemoteq AG
PINOVA Capital has invested in medical technology company Hemoteq AG in Würselen.
Altor-backed Apotek Hjärtat acquires Ada AB
Altor-backed pharmaceutical business Apotek HjУЄrtat has wholly acquired Ada AB from its parent Tamro Group for an undisclosed sum.
Healthcare buyouts: a tonic for the market
Defensive sector or not, buyout activity in the healthcare area was as depressed as elsewhere during 2009. But things are looking up and a spate of deal completions and possible exits in the first few months of 2010 are providing a welcome tonic for a...
EQT to sell Aleris for SEK 4bn
Reports suggest that EQT is set to sell health care group Aleris, potentially valuing the business at SEK 4bn.
Galantos Pharma secures €4.4m
A large consortium of state and regional entities has backed drug company Galanthos Pharma with €4.4m of series C of funding.
Polaris divests Frösunda to HgCapital
Pan-European investor HgCapital has acquired FrУЖsunda LSS from Danish private equity firm Polaris for an undisclosed sum.
Consortium raises €20m Series C for Affimed
Existing investors aeris Capital, BioMedInvest, LSP Life Sciences Partners, Novo Nordisk A/S and Orbimed have provided €20m in in a Series-C financing round for Affimed Therapeutics AG.
CapMan acquires Esperi
CapMan has acquired care services company Esperi from an investor consortium led by Unicus, management and the Finnish Red Cross.
Fitness investments: Working their way back to health
The recent wave of private equity-backed expansion deals in the gym industry suggests it is a sector in rude health. Francois Rowell investigates.
ERIP et al. in €8m round for Implanet
Edmond de Rothschild Investment Partners (ERIP), has led an €8m round for Implanet SA, a French developer of surgical implants for orthopedic and spine surgery, along side CM-CIC Private Equity, Wellington Partners and Seventures Partners.
NVM sets up RCC Lifesciences
NVM Private Equity has backed the ТЃ3m launch of RCC Lifesciences Limited. The acquisition vehicle will target development capital opportunities within the UK healthcare sector and primarily the lifesciences and medical devices markets.
Inventure et al exit Proxeon to Thermo Fisher Scientific
Inventure Capital, Vecata and VУІkstfonden have divested their stake in scientific instrument maker Proxeon A/S to US trade buyer Thermo Fisher Scientific Inc. The terms of the deal were not disclosed.
CDC Enterprises in $18m round for biospace med
CDC Entreprises, (acting on behalf of the Strategic Investment Fund -SIF), has participated in an $18m round for biospace med alongside existing investors Edmond de Rothschild Investment Partners, Crédit Agricole Private Equity, UFG Private Equity, NBGI...
HTGF and KI Kapital invest in SAW Instruments
High-Tech Gründerfonds and KI Kapital GmbH have invested in start-up SAW Instruments GmbH.
Gimv hires DACH life sciences partner
Gimv has hired Annegret de Baey-Diepolder as a partner to join the firm’s life sciences in the DACH region; she will be base in Munich.
Norinnova and Sarsia Seed back Prophyllix Pharma,
Norinnova Forvaltning, via Norinnova Invest, has alongside Sarsia Seed invested in Norwegian life science company Prophyllix Pharma, each taking a 7.7% stake.
Arax backs Biocrates Life Science with €1.2m
Arax Capital Partners has funded metabolic biomarker company Biocrates Life Science AG with €1.2m as a first tranche of a fundraising round.
Aescap et al. in €30m Biocartis round
Aescap, alongside other existing backers and new strategic investors Debiopharm Group and Johnson & Johnson, has particpated in a €30m series B funding round for Biocartis SA.
Abingworth invests in €33m round for Epigenomics
Abingworth has invested in listed biotech company Epigenomics AG as part of an oversubscribed €33.1m fundraising round.
EnjoyVenture leads funding for amedo Smart Tracking
EnjoyVenture has led a follow-on round of funding for amedo Smart Tracking Solutions, alongside High-Tech Gründerfonds, the KfW banking group and new strategic investors.